Alkem Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : ALKEM
NIFTY : NIFTY Midcap 100
NIFTY SECTOR : Nifty Pharma

About Company

Alkem Laboratories Limited is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments. The Company is a leading player in the acute therapeutic segment and a fast-growing player in the chronic therapeutic segment. India operations are underpinned by a robust sales and distribution network and extensive brand building and marketing efforts. The Company’s International business, built on a strong platform of a large and growing product pipeline, is a core part of its growth. These products are distributed through the Company’s own sales and commercial infrastructure.

Market Cap. ₹60,691 Cr.

52 Week - High/Low ₹6,440/4,407

P/E Ratio 26.59

P/B Ratio 5.75

Enterprise Value ₹58,715 Cr.

ROE % 17.56

RSI Value 56.27

EMA 50 4966.6

EMA 200 5165.37

Net Profit 1,747 Cr.

Net Profit 3year growth 3.68 Cr.

Net Profit 3 year (back) 1,685 Cr.

Debt to Equity 0.09 %

EPS Growth TTM 14.7 %

Current Ratio 2.59 %

100 Day SMA 5,069 Rs.

200 Day SMA 5,437 Rs.

21 Day SMA 4,963 Rs.

50 Day SMA 4,846 Rs.

Book Value 883 Rs.

EV/EBITDA Ratio 20

QoQ EPS Growth -3 %

QoQ Operating Profit Growth -10 %

QoQ Sales Growth -20 %

Sales Latest Quarter 2,287 Cr.

YoY Sales Growth 14 %

Market Cap. ₹60,691 Cr.

52 Week - High/Low ₹6,440/4,407

P/E Ratio 28.18

P/B Ratio 5.89

Enterprise Value ₹58,463 Cr.

ROE % 18.74

RSI Value 56.27

EMA 50 4966.6

EMA 200 5165.37

Net Profit 1,796 Cr.

Net Profit 3year growth 6.96 Cr.

Net Profit 3 year (back) 1,585 Cr.

Debt to Equity 0.12 %

EPS Growth TTM 36.87 %

Current Ratio 2.61 %

100 Day SMA 5,069 Rs.

200 Day SMA 5,437 Rs.

21 Day SMA 4,963 Rs.

50 Day SMA 4,846 Rs.

Book Value 862 Rs.

EV/EBITDA Ratio 20

QoQ EPS Growth -9 %

QoQ Operating Profit Growth 1 %

QoQ Sales Growth -1 %

Sales Latest Quarter 3,374 Cr.

YoY Sales Growth 2 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages